Potential Consequences of the Red Blood Cell Storage Lesion on Cardiac Electrophysiology by Reilly, Marissa et al.
Himmelfarb Health Sciences Library, The George Washington University 
Health Sciences Research Commons 
Pediatrics Faculty Publications Pediatrics 
11-3-2020 
Potential Consequences of the Red Blood Cell Storage Lesion on 
Cardiac Electrophysiology 
Marissa Reilly 
Chantel D. Bruno 
Tomas M. Prudencio 
Nina Ciccarelli 
Devon Guerrelli 
See next page for additional authors 
Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs 
 Part of the Pediatrics Commons 
APA Citation 
Reilly, M., Bruno, C. D., Prudencio, T. M., Ciccarelli, N., Guerrelli, D., Nair, R., Ramadan, M., Luban, N. L., & 
Posnack, N. G. (2020). Potential Consequences of the Red Blood Cell Storage Lesion on Cardiac 
Electrophysiology. Journal of the American Heart Association, 9 (21). http://dx.doi.org/10.1161/
JAHA.120.017748 
This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research 
Commons. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of 
Health Sciences Research Commons. For more information, please contact hsrc@gwu.edu. 
Authors 
Marissa Reilly, Chantel D. Bruno, Tomas M. Prudencio, Nina Ciccarelli, Devon Guerrelli, Raj Nair, Manelle 
Ramadan, Naomi L C Luban, and Nikki Gillum Posnack 
This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/
smhs_peds_facpubs/6170 
Journal of the American Heart Association
J Am Heart Assoc. 2020;9:e017748. DOI: 10.1161/JAHA.120.017748 1
 
ORIGINAL RESEARCH
Potential Consequences of the Red 
Blood Cell Storage Lesion on Cardiac 
Electrophysiology
Marissa Reilly, MS*; Chantal D. Bruno, DO*; Tomas M. Prudencio, MS; Nina Ciccarelli, BS; Devon Guerrelli, MS; 
Raj Nair, BS; Manelle Ramadan, BS; Naomi L. C. Luban, MD; Nikki Gillum Posnack , PhD
BACKGROUND: The red blood cell (RBC) storage lesion is a series of morphological, functional, and metabolic changes that 
RBCs undergo following collection, processing, and refrigerated storage for clinical use. Since the biochemical attributes of 
the RBC unit shifts with time, transfusion of older blood products may contribute to cardiac complications, including hyper-
kalemia and cardiac arrest. We measured the direct effect of storage age on cardiac electrophysiology and compared it with 
hyperkalemia, a prominent biomarker of storage lesion severity.
METHODS AND RESULTS: Donor RBCs were processed using standard blood-banking techniques. The supernatant was col-
lected from RBC units, 7 to 50 days after donor collection, for evaluation using Langendorff-heart preparations (rat) or human 
induced pluripotent stem cell–derived cardiomyocytes. Cardiac parameters remained stable following exposure to “fresh” 
supernatant from red blood cell units (day 7: 5.8±0.2 mM K+), but older blood products (day 40: 9.3±0.3 mM K+) caused 
bradycardia (baseline: 279±5 versus day 40: 216±18 beats per minute), delayed sinus node recovery (baseline: 243±8 versus 
day 40: 354±23 ms), and increased the effective refractory period of the atrioventricular node (baseline: 77±2 versus day 
40: 93±7 ms) and ventricle (baseline: 50±3 versus day 40: 98±10 ms) in perfused hearts. Beating rate was also slowed in 
human induced pluripotent stem cell–derived cardiomyocytes after exposure to older supernatant from red blood cell units 
(−75±9%, day 40 versus control). Similar effects on automaticity and electrical conduction were observed with hyperkalemia 
(10–12 mM K+).
CONCLUSIONS: This is the first study to demonstrate that “older” blood products directly impact cardiac electrophysiology, 
using experimental models. These effects are likely caused by biochemical alterations in the supernatant from red blood cell 
units that occur over time, including, but not limited to hyperkalemia. Patients receiving large volume and/or rapid transfusions 
may be sensitive to these effects.
Key Words: cardiac electrophysiology ■ hyperkalemia ■ red blood cell storage lesion
More than 13 million whole blood and red blood cell (RBC) units are transfused in the United States each year, with cardiac surgical proce-
dures accounting for ≈20% of all blood transfusions.1–7 
Many cardiac procedures mandate the use of blood 
and blood products in the preoperative, intraoperative, 
and postoperative period, particularly with infant and 
pediatric patients for cardiopulmonary bypass circuitry 
priming.3,8 Despite the frequency, transfusion of blood 
and blood products is not without risk.9,10 Transfusion of 
RBCs in particular has been associated with increased 
morbidity and mortality, prolongation of hospital stay, 
and several different cardiac complications.9–17 Many 
investigators have suggested that RBC transfusion 
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complications are caused by the transfusion of RBCs 
close to their expiration (42 days), wherein the effects 
of the RBC storage lesion can contribute to the patho-
biology of adverse reactions.12,14,18–25 These pathobio-
logical changes include clearance of storage-damaged 
RBCs, aberration of nitric oxide metabolism, trapping 
of RBCs by macrophages resulting in oxidative dam-
age and impaired oxygen delivery, and an increase 
in circulating nontransferrin bound iron.24,26–28 Briefly, 
over time, stored RBCs are depleted of ATP, which al-
ters the RBC cell membrane, resulting in hemolysis, 
the formation of RBC microvesicles, release of intracel-
lular iron, decreased nontransferrin bound iron, and the 
release of free hemoglobin. Furthermore, the pH and 
electrolyte composition of the RBC unit also changes 
because of continued anaerobic metabolism and dys-
function of cation transporters. The latter includes 
impairment of Na+/K+ ATPase,29 which leads to a pro-
gressive increase of extracellular [K+] in the RBC unit 
supernatant.30,31 Consequently, rapid or large-volume 
transfusions of RBC units with elevated potassium 
levels can predispose patients to hyperkalemia, con-
duction abnormalities, and cardiac arrest.14,15,18,19,22,32 
Although the incidence of transfusion-associated hy-
perkalemia is poorly defined and potentially underre-
ported,14 Raza et al. noted elevated K+ levels in >70% 
of adult trauma patients following transfusion,18 and 
Livingston et al. observed hyperkalemia in 18% to 23% 
of pediatric trauma patients following transfusion.33 
Transfusion-associated hyperkalemia resulting in car-
diac arrest is a recognized complication of massive 
transfusion in children, with a mean serum [K+] level 
of 9.2±1.8 mM in patients who experienced cardiac ar-
rest.14 Some investigators suggest that the risk factors 
for transfusion-associated hyperkalemia resulting in 
cardiac arrest include the volume and rate of transfu-
sion, storage age, and irradiation of RBCs, but the per-
ceived risk and reason for such cardiac complications 
remain actively debated.14,31,34,35
Chronological storage age is one of the key fac-
tors that influence RBC quality and storage lesion 
severity.29,30,36 Despite this, blood banks often em-
ploy a “first-in, first-out” approach to reduce blood 
product waste and maintain an inventory supply to 
support emergency transfusions. Indeed, it is esti-
mated that 10% to 20% of RBC units are transfused 
after 35 days of refrigerated storage, or near their 
42-day expiration date.37 Some investigators have 
recommended a reduction in the maximum allow-
able storage time for RBCs because of quality con-
cerns.18,24,27,38–41 Several clinical studies have raised 
concerns about the effects of the RBC storage le-
sion14,15,20,22,23,42,43; however, the direct impact of 
RBC quality on cardiac health outcomes remains un-
clear. Identifying a mechanistic relationship between 
RBC quality and adverse cardiac end points has 
been hindered in the clinical setting by confounding 
factors, including disease diagnosis, age, rate/site of 
infusion, volume of transfusion per unit time, number 
of transfusions, bypass and cross-clamp time, sec-
ondary complications from surgery, and concomi-
tant medication administration. Recent randomized 
clinical trials have demonstrated that transfusion 
with fresh blood (1–10  days storage duration) does 
not decrease the risk of mortality compared with 
standard practice (2–3 weeks storage duration).44–48 
However, considerably less is known about the risk 
of transfusing RBCs near expiration (35–42 days), or 
the impact on secondary end points including car-
diac complications.35,49–51
We aimed to address clinical concerns of bra-
dycardia and cardiac arrest by investigating the di-
rect relationship between RBC storage age and 
CLINICAL PERSPECTIVE
What Is New?
• This study is the first to demonstrate that 
“older” red blood cell products (as compared 
with “fresh” products) may directly impact myo-
cardial automaticity and electrical conduction, 
using experimental cardiac models.
What Are the Clinical Implications?
• Transfusion-induced hyperkalemic cardiac 
arrest is a recognized complication of trans-
fusions; our study suggests that cardiac com-
plications could be linked to high potassium 
concentrations in red blood cells units that are 
close to expiration.
Nonstandard Abbreviations and Acronyms
AS-1 or AS-3 additive solution-1 or additive 
solution-3
AVNERP atrioventricular node effective 
refractory period
hiPSC-CM human induced pluripotent stem 
cell–derived cardiomyocytes
KH Krebs-Henseleit media
MEA microelectrode array
RBC red blood cell
SNRT sinus node recovery time
sRBC supernatant from red blood cell 
units
VERP ventricular effective refractory 
period
WBCL Wenckebach cycle length
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myocardial function using experimental models. We 
hypothesized that electrical conduction would be im-
paired in cardiac models exposed to the superna-
tant of “old” RBC (sRBC) units close to expiration as 
compared with “fresh” units, in part because of ele-
vated extracellular potassium that can alter the myo-
cardial resting membrane potential.22,52–54 To test 
this hypothesis, electrophysiology parameters were 
measured using both an intact, isolated rat heart 
preparation and human induced pluripotent stem 
cell–derived cardiomyocytes (hiPSC-CM). Cardiac 
end points were measured at baseline, and again 
after exposure to sRBC collected from “fresh” (day 7 
postdonor collection), “old” (day 30–40), or “expired” 
units (day 50). We compared these results with those 
observed with hyperkalemia, a primary biomarker of 
RBC storage lesion severity.29,30,36
METHODS
Data that support the findings of this study are avail-
able from the corresponding author upon reason-
able request. Animal protocols were approved by the 
Institutional Animal Care and Use Committee of the 
Children’s National Research Institute, and followed 
the National Institutes of Health’s Guide for the Care 
and Use of Laboratory Animals.
RBC Sample Preparation
RBC units (300±50  mL) from healthy donors were 
obtained from the American Red Cross or Children’s 
National Blood Donor Center. All units were type O 
blood, sickle-negative, nonirradiated, collected using 
standard single-donor needle methods, and stored in 
additive preservative solution (AS-1 or AS-3) accord-
ing to standards of the American Academy Blood 
Banking requirements and the US Food and Drug 
Administration.55 Single RBC units were stored at 4 
to 6°C in a research-grade, temperature-monitored 
refrigerator according to standards.55 RBC units un-
derwent gentle centrifugation (4°C, 20 minutes, 2000g; 
Haemonetics) using accumulated centrifugal effect 
value of 6.5 × 107 to separate and collect the superna-
tant (sRBC) 7 to 50 days postdonor collection; sRBC 
samples were used for subsequent experiments. 
Experiments were designed to study the impact of 
RBC storage lesion on cardiac electrophysiology, by 
comparing end points after exposure to “fresh” sRBC 
(7 days postdonor collection), “old” sRBC (30–40 days), 
or “expired” sRBC (50 days).
General Protocol and Biochemical Analysis
Trauma patients and patients undergoing cardiac 
surgery or extracorporeal membrane oxygenation 
can receive large transfusion volumes ≥60% of the 
patient’s total blood volume.56,57 As examples, an es-
timated 3% to 8% of civilian trauma patients and 10% 
of military trauma patients receive large-volume RBC 
transfusions,58,59 while >90% of children undergo-
ing cardiopulmonary bypass receive packed RBCs 
(average 3.4 RBC units for complex procedures).60 
To mimic exposure, we estimated 10% superna-
tant volume exposure from reconstituted blood (½ 
volume packed RBCs [20–30% supernatant con-
taining anticoagulant and 70–80% RBCs] and ½ 
volume plasma). Accordingly, sRBC samples were 
diluted to 10% volume using Krebs-Henseleit (KH) 
buffered media (denoted in mM: 118 NaCl, 3.29 KCl, 
1.2 MgSO4, 1.12 KH2PO4, 24 NaHCO3, 10 glucose, 2 
C3H3NaO3, 10 HEPES, and 0.33 CaCl). Biochemical 
analyses were performed on each diluted sRBC 
sample, using an Epoc® point-of-care blood analy-
sis system (Siemens Diagnostics: SMNS10736382) 
to measure Na+, K+, Ca2+, Cl−, and lactate levels. pH 
measurements were performed using an Oakton 
700 pH meter, and osmolarity was assessed using 
an Advanced Instruments 3300 micro-osmometer 
(Table 1).
Table 1. Biochemical Analyses of sRBC Diluted to 10% Volume in KH-Buffered Media
Parameter (mmol/L)
Days of Storage
KH Media 7 30–35 40 50
pH 7.38±0.01 7.40±0.01 7.41±0.01 7.40±0.003 7.41±0.01
Osmolarity, mOsm/L 315±0.58 314±2.65* 315±0.86 318±1.86 319±1.67
K+ 4.48±0.04 5.82±0.16* 9.28±0.41*,** 9.28±0.33*,** 9.65±0.26*,**
Lactate 0.30±0.002 0.79±0.96 2.76±0.24*,** 2.42±0.17*,** 2.98±0.20*,**
Cl− 117.9±0.51 117.9±0.23 117.6±0.32 116.7±0.61 119.3±0.33
Ca2+ 1.70±0.05 1.14±0.11* 0.97±0.10* 1.10±0.13* 1.27±0.11*
Na+ 151±0.32 149±0.34* 145±0.45*,** 145±0.80*,** 147±0.33*,**
Storage age was associated with deviations in the electrolyte composition of sRBC samples. Mean±SEM. KH indicates Krebs-Henseleit media; and sRBC, 
supernatant from red blood cell units.
*Value differs significantly from control KH buffer, or **Value differs from day 7 sample (P<0.05). n=3–10 per group.
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Intact, Whole Heart Preparations
Experiments were conducted using adult, female 
Sprague-Dawley rats (>8 weeks old, >200 g, Taconic 
Biosciences). Animals were housed in conventional rat 
cages in the Research Animal Facility under standard 
environmental conditions (12:12 hour light:dark cycle, 
64–78°F, 30–70% humidity, free access to reverse 
osmosis water, corncob bedding, and food [2918 ro-
dent chow, Envigo]). Animals were anesthetized with 
3% to 5% isoflurane; the heart was then excised and 
transferred to a temperature-controlled (37°C), con-
stant-pressure (70  mm  Hg) Langendorff-perfusion 
system for electrophysiology experiments (Figure  1). 
After isolating and transferring the heart to the perfu-
sion system, excised hearts were perfused with Krebs-
Henseleit buffer bubbled with carbogen (95% oxygen, 
5% CO2) throughout the duration of the experiment.
61 
Pseudo-ECGs were continuously recorded in lead II 
configuration during sinus rhythm; ECG signals were 
analyzed to quantitate heart rate, atrioventricular con-
duction (PR interval), ventricular depolarization time 
(QRS width), ventricular repolarization (QTc),62 and ar-
rhythmia incidence.63–65 Biosignals were acquired in 
iox2 and ECG parameters were analyzed in ecgAUTO 
(emka Technologies).
Electrophysiology Measurements
To further investigate cardiac electrophysiology, a pac-
ing protocol was implemented using stimulation elec-
trodes positioned on the right atrium and the apex of 
the left ventricle (Figure 1).63,65 A Bloom Classic elec-
trophysiology stimulator (Fisher Medical) was set at 
a pacing current 1.5× the minimum pacing threshold 
(1–2  mA) with 1-ms monophasic pulse width. Sinus 
node recovery time (SNRT) was assessed by apply-
ing a pacing train of 150 ms (S1−S1) to the right atrium 
and measuring the time delay until the next sponta-
neous sinoatrial node–mediated activity. To determine 
the Wenckebach cycle length (WBCL), an S1–S1 pac-
ing interval was applied to the right atrium; the pacing 
cycle length was decremented stepwise to pinpoint 
the shortest interval that resulted in 1:1 atrioventricu-
lar conduction. Next, an S1–S2 pacing interval was 
applied to the right atrium to determine the atrioven-
tricular nodal effective refractory period (AVNERP). An 
S1–S2 pacing interval was applied to the left ventricle 
to find the shortest coupling interval that resulted in 1:1 
ventricular depolarization, signifying the ventricular ef-
fective refractory period (VERP).
Experimental Timeline and Treatment Groups
Isolated, intact hearts were perfused with KH media for 
30 minutes, followed by implementation of electrophysiol-
ogy pacing protocols (“baseline”). Hearts were then per-
fused for another 15 to 20 minutes, with either KH media 
alone (control), media supplemented with 10% sRBC 
(7–50 days postdonor collection), or media supplemented 
with elevated potassium concentrations (6–12 mM KCl). 
Electrophysiology protocols were performed a second 
time to determine the effects of sRBC treatment or hyper-
kalemia on electrical conduction (Figure 1). This protocol 
allowed each animal to serve as its own control, and ac-
count for experimental or animal variability.
hiPSC-CM Preparation and Microelectrode 
Array Recordings
hiPSC-CM (iCell, Cellular Dynamics International) are 
commonly used as a model to detect drug-induced 
changes in cardiac electrophysiology, including use 
in the comprehensive in vitro proarrhythmia assay in-
itiative.66,67 This cell line contains a mixed population 
of cardiomyocytes with nodal, atrial, and ventricular-
like electrophysiological properties that resemble na-
tive cardiomyocytes.68 hiPSC-CM were plated onto 
fibronectin-coated microelectrode arrays (MEA 24, 
Axion Biosystems), at a density of 30 000 cells per 
well. hiPSC-CM were maintained under standard 
cell culture conditions (37ºC, 5% CO2). hiPSC-CM 
formed a confluent contracting monolayer (40–60 
beats per minute) and MEA recordings were per-
formed 7 to 10  days after plating to measure the 
spontaneous beating rate. hiPSC-CM were equili-
brated in the MEA system for 15 minutes, and then 
the spontaneous beating rate was recorded (“base-
line”) using an integrated MEA system (Maestro Edge, 
Axion Biosystems) with temperature and gas control 
(37ºC, 5% CO2). Cardiomyocytes were then treated 
Figure 1. Heart preparation and experimental timeline
A, Isolated, intact rodent heart with retrograde Langendorff-
perfusion via an aortic cannula. Pacing electrodes were attached 
to the RA and apex of the LV to perform an EP. B, Experimental 
timeline included 30-minutes perfusion with KH media, 
containing 4.5 mM K+ (control), which commenced with an EP 
protocol. Thereafter, the media remained unchanged (control), 
supplemented with 10% sRBC, or supplemented with increasing 
potassium concentrations. The EP study was repeated 
again after 15–20  minutes, and results were compared with 
baseline. Timeline created using biorender.com. EP indicates 
electrophysiology study; KH, Krebs-Henseleit media; LV, left 
ventricle; RA, right atria; and sRBC, supernatant from red blood 
cell units.
D
ow
nloaded from
 http://ahajournals.org by on A
ugust 6, 2021
J Am Heart Assoc. 2020;9:e017748. DOI: 10.1161/JAHA.120.017748 5
Reilly et al Storage Lesion and Cardiac Electrophysiology
for 5 minutes with iCell maintenance media (control), 
media supplemented with 10% sRBC (7 to 40 days 
postdonor collection), or media supplemented with 
elevated potassium concentrations (9–12  mM). 
Spontaneous beating rate was also recorded 1 hour 
posttreatment and after washout. To account for cell 
plating variability, each treated cardiomyocyte mon-
olayer was compared to baseline.69
Statistical Analysis
Results are reported as mean±SEM. Data normality was 
assessed by Shapiro-Wilk testing (GraphPad Prism). For 
sRBC measurements, end points were measured be-
fore and after treatment within the same heart (baseline 
versus treatment) and statistical analysis was performed 
using either a 2-tailed paired t test (passed normality 
test) or Wilcoxon matched-pairs signed rank test (failed 
normality test). For hyperkalemia studies with multiple 
doses, statistical analysis was performed using either 
1-way ANOVA (passed normality test) or Kruskal-Wallis 
nonparametric test (failed normality test), with a false 
discovery rate (0.1) to correct for multiple comparisons. 
Significance was defined by *P<0.05.
RESULTS
Storage Age Affects the Biochemical 
Composition of sRBC
The attributes of a stored blood product shifts as RBC 
quality declines, which can result in an accumulation 
of potassium in the supernatant.29,30,36 To measure 
the effect of storage time on the electrolyte compo-
sition of blood units, sRBC samples were collected 
from RBC units on day 7 to 50 postdonor collection, 
samples were diluted to 10% volume using pH-buff-
ered KH media, and then electrolyte-gas measure-
ments were performed on the diluted end product 
(Table 1). Extracellular potassium levels were elevated 
in “old” units as compared with “fresh” units (day 7: 
5.8±0.2 versus day 40: 9.3±0.3  mM, P<0.0001); but 
there was variability between age-matched units near 
expiration ranging from 7.5 to 11.9 mM [K+] in the 10% 
diluted end product (day 30–50). Lactate levels were 
elevated in older blood units (day 7: 0.8±1 versus day 
40: 2.4±0.2 mM, P <0.0001), and sodium concentra-
tion declined slightly with storage age (day 7: 149±0.3 
versus day 40: 145±0.8 mM, P <0.0001). pH and os-
molarity values were similar between preparations.
Storage Age Is Associated With Heart 
Rate Slowing and Sinus Node Dysfunction
Cardiac complications from RBC transfusion in-
clude an increased risk of bradycardia and cardiac 
arrest.14,15,18,21 These adverse outcomes may be pre-
cipitated by elevated extracellular potassium, which 
diminishes the myocardial resting membrane po-
tential.53,54 Accordingly, we assessed the impact of 
sRBC exposure on spontaneous heart rate and sinus 
node function in Langendorff-perfused hearts. Heart 
rate remained stable throughout the study when 
Figure 2. RBC storage age is associated with heart rate 
slowing and sinus node dysfunction
A, Biosignals recorded from isolated hearts perfused with media 
supplemented with 10% sRBC collected from a day 7 unit, or 
(B) day 40 unit. ECGs were recorded during sinus rhythm (RR 
interval highlighted), followed by train of atrial paces (black 
arrowheads denote pacing spikes). Each atrial pace results 
in a ventricular response. SNRT was measured from the last 
pacing spike to resumption of sinus rhythm. C, Stable heart rate 
following exposure to RBC units aged 7–30 d, but bradycardia 
observed with sRBC collected from units aged  ≥  40  d. D, HR 
slowing observed at highest potassium concentration tested 
(12 mM K+). E, Exposure to day 40 sRBC resulted in slowed sinus 
node recovery, or complete cessation of sinus function with day 
50 sRBC. F, Increased SNRT also observed at highest potassium 
concentration tested (12 mM K+). Mean±SEM, *P<0.05, n=3–6. 
BPM indicates beats per minute; HR, heart rate; RBC, red blood 
cell; SNRT, sinus node recovery time; and sRBC, supernatant 
from red blood cell units.
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perfused with control media containing 4.5  mM  K+ 
(baseline: 297±10 versus 45 minutes: 288±15 beats 
per minute), and also remained stable when the per-
fusate was supplemented with 10% sRBC collected 
from RBC units aged 7 to 30  days (Figure  2). 
Similarly, sinus node function remained stable with 
control media perfusion (SNRT baseline: 223±14 ver-
sus 45 minutes: 238±9) and following perfusion with 
Figure 3. RBC storage age is associated with slowed atrioventricular conduction
A, Pseudo-ECGs recorded during sinus rhythm from isolated hearts perfused with control media (left), media supplemented with 10% 
sRBC collected from a day 7 unit (middle) or day 40 unit (right). PR interval time is denoted. (B,C) Atrioventricular conduction slows 
in the presence of day 40 and day 50 sRBC, or 10–12 mM K+. (D,E) Exposure to sRBC units had no measurable effect on ventricular 
depolarization time (QRS) during sinus rhythm. Mean±SEM, *P<0.05, n=3–6. RBC indicates red blood cell; and sRBC, supernatant 
from red blood cell units.
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Figure 4. RBC storage age is associated with increased refractoriness of the AV node
A, Biosignals recorded with atrial pacing (S1-S1) to measure WBCL in isolated hearts in the presence of day 7 sRBC, 
(B) day 40 sRBC, or (C) 10 mM K+. D, Slowed AV node conduction following exposure to sRBC from older units, but 
not “fresh” day 7 units. E, Slowed AV conduction following exposure to 10–12 mM K+. Arrowheads denote ventricular 
response to atrial pacing at S1 (black) pacing cycle length. ≠ denotes failed conduction. Mean±SEM, *P<0.05, n≥3. AV 
indicates atrioventricular; sRBC, supernatant from red blood cell units; and WBCL, Wenckebach cycle length.
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Figure 5. RBC storage age is associated with an increased AV node effective refractory period
A, Biosignals recorded with atrial pacing (S1–S2) to pinpoint AVNERP in the presence of day 7 sRBC, (B) day 40 sRBC, or 
(C) 10 mM K+. D, AVNERP did not change after exposure to day 7–30 sRBC, but increased with day 40 and day 50 sRBC 
exposure. E, AVNERP increased with severe hyperkalemia. Arrowheads denote ventricular response to atrial pacing at 
S1 (black) or S2 (gray) pacing cycle length. ≠ denotes failed conduction. Mean±SEM, *P<0.05, n=3–6. AVNERP indicates 
atrioventricular node effective refractory period; RBC, red blood cell; sRBC, supernatant from red blood cell units.
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10% sRBC collected from units aged 7 to 30 days 
(Figure 2). However, as RBC units neared expiration, 
sRBC exposure slowed the heart rate by 23% (base-
line: 279±5 versus day 40: 216±18 beats per minute, 
P<0.005). Additionally, sRBC from day 40 units had 
a significant effect on sinus node function, delaying 
the recovery time by 46% (SNRT baseline: 243±8 ms 
versus day 40: 354±23 ms, P<0.005). In the latter, 
the perfusate media had a mean potassium concen-
tration >9 mM (Table 1). To measure the direct effect 
of hyperkalemia on automaticity and sinus function, 
a dose–response study was performed. As the po-
tassium concentration increased from 4.5 to 12 mM, 
heart rate slowed (linear regression R2 = 0.92, P=0.01) 
and SNRT was prolonged (R2 = 0.86, P=0.02).
Storage Age Is Associated With 
Atrioventricular Conduction Slowing
Electrochemical gradients across the cardiomyo-
cyte membrane are essential for cardiac excitation 
and electrical propagation. Atrial cardiomyocytes are 
particularly sensitive to deviations in these electro-
chemical gradients, and an increase in extracellular 
potassium can slow atrioventricular conduction.32,53,70 
Atrioventricular conduction remained constant in 
hearts perfused with control KH media throughout the 
study (Figure  3), as determined by ECG parameters 
during sinus rhythm (PR time at baseline: 33±4 ver-
sus 45 minutes: 36±2). Similar results were observed 
before and after exposure to 10% sRBC samples col-
lected from units aged 7 to 30 days, but significant 
slowing was observed after exposure to sRBC near or 
after expiration (PR time at baseline: 33±1 versus day 
40: 41±3 ms, P<0.05; PR time at baseline: 37±1 ver-
sus day 50: 53±8 ms, P<0.005). Atrioventricular node 
refractoriness was further interrogated by implement-
ing an atrial pacing protocol to measure WBCL (S1-S1 
pacing) and AVNERP (S1-S2 pacing). These parame-
ters remained unchanged in hearts perfused with con-
trol media (WBCL baseline: 79±2 versus 45 min: 83±2; 
AVNERP baseline: 64±5 versus 45  minutes: 67±4) 
and hearts exposed to sRBC from “fresh” 7-day units 
(Figures 4 and 5). Exposure to day 30 sRBC resulted in 
a modest increase in AV node refractoriness, increas-
ing WBCL by 9%. Effects on the AV node were more 
pronounced after exposure to day 40 sRBC, which in-
creased AVNERP by 21% (baseline: 77±2 versus day 
40: 93±7  ms, P=0.01) and WBCL by 19% (baseline: 
90±1 versus day 40: 107±3 ms, P<0.001). A 66% in-
crease in AVNERP was observed in units stored past 
expiration (baseline versus day 50 sRBC; Figure 5).
As anticipated, a dose–response relationship was 
observed when the potassium concentration was 
increased in the perfusate media, resulting in pro-
longed atrioventricular conduction time and increased 
atrioventricular node refractoriness. As the potassium 
concentration increased from 4.5 to 12  mM, a pro-
gressive increase in PR duration (R2  =  0.85, P<0.05) 
was observed (Figure 3). At 10 mM K+ (a concentration 
comparable to day 40 sRBC-supplemented media), a 
51% increase in WBCL was observed (4.5 mM: 84±3 to 
10 mM: 127±13 ms, P<0.005), but changes in AVNERP 
were only observed at 12  mM  K+ (4.5  mM: 71±3 to 
12 mM: 151±21 ms, P<0.005; Figures 4 and 5). The lat-
ter suggests that other factors or substances in the RBC 
supernatant may also contribute to conduction slowing.
Storage Age Increases Ventricular 
Refractoriness
Severe hyperkalemia is associated with decreased so-
dium channel availability and slowed conduction veloc-
ity, which results in QRS widening and may precipitate 
ventricular tachyarrhythmias.32,53,70 In our model, ex-
posure to sRBC-supplemented media did not sig-
nificantly alter the QRS duration (baseline: 26±2  ms 
versus day 40: 34±9 ms; Figure 3), QTc duration (base-
line: 169±9 versus day 40: 172±11 ms), or increase the 
incidence of ventricular tachyarrhythmias (data not 
shown). Furthermore, we were not able to establish a 
linear trend toward QRS prolongation with increasing 
potassium concentration (R2 = 0.72, P=0.07), QTc du-
ration (R2 = 0.67, P=0.67) or an increased incidence of 
ventricular tachyarrhythmias, which may be attributed 
to limitations in our model system. Indeed, ventricu-
lar activation and early repolarization can occur si-
multaneously in the rodent heart, which can influence 
the QRS complex and result in indistinct T-waves.71 
Moreover, the rodent myocardium is less than ideal for 
assessing arrhythmia incidence because of its small 
size and resilience to fibrillation.71 As another indica-
tor of ventricular repolarization time, we implemented a 
pacing protocol to pinpoint ventricular refractoriness. A 
marginal increase in extracellular potassium can has-
ten repolarization and shorten action potential duration 
time, but severe hyperkalemia increases postrepolari-
zation refractoriness.54,72,73 As expected, control media 
perfusion resulted in stable VERP measurements 
throughout the study (VERP baseline: 45±5 versus 
45 minutes: 46±2 ms). VERP measurements were un-
changed in heart preparations exposed to sRBC from 
day 7 to 30 RBC units (Figure 6), but VERP increased 
by 96% following exposure to day 40 sRBC (base-
line: 50±3 versus day 40: 98±10 ms, P<0.0001) and 
145% after exposure to expired units (baseline: 51±8 
versus day 50: 126±25 ms, P<0.0001). This increase 
in ventricular refractoriness may be explained, at least 
partly, by the increase in extracellular potassium levels. 
In dose–response studies, increasing potassium con-
centration (4.5–12 mM) also resulted in a progressive 
increase in VERP (linear regression, R2 = 0.91, P=0.01).
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Figure 6. RBC storage age is associated with increased ventricular refractoriness
A, Biosignals recorded with ventricular pacing (S1–S2) to pinpoint the VERP in isolated hearts perfused with media supplemented 
with 10% sRBC collected from a day 7 unit, (B) day 40 unit, or (C) 10 mM K+. D, Ventricular refractoriness was unchanged after 
exposure to day 7–30, but increased with day 40–50 sRBC and (E) media supplemented with 8–12 mM K+. Arrowheads denote 
ventricular response to pacing at S1 (black) or S2 (gray) pacing cycle length. ≠ denotes failed conduction. Mean±SD, *P<0.05, 
n=3–6. RBC indicates red blood cell; sRBC, supernatant from red blood cell units; and VERP, ventricular effective refractory period.
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hiPSC-CM Are Susceptible to Electrical 
Disturbances
Rodent models are frequently employed in cardio-
vascular research studies, although species-specific 
differences in ion channel expression are estab-
lished.74,75 Accordingly, we performed a follow-up 
study using hiPSC-CM to validate the effects of 
sRBC exposure. Using a MEA system, we noted an 
increase in the beating rate of hiPSC-CM over time 
when treated with day 7 sRBC (5 minutes: 12±6% rate 
increase P=0.09 versus 60 minutes: 33±5% P<0.005, 
Figure 7). Conversely, cardiomyocytes demonstrated 
bradycardia after exposure to “older” sRBC products, 
which was more severe than reported in the whole 
heart experiments. The spontaneous beating rate of 
hiPSC-CM decreased by 47±7% in day 35 samples 
and 75±9% in day 40 samples relative to baseline 
measurements (P<0.0001). Significant slowing in the 
spontaneous beating rate was also observed with 
increasing potassium concentrations (4.5–12 mM K+; 
Figure 7. Reduced automaticity in hiPSC-CM
A, Microelectrode array heat map shows 16-electrode recordings from hiPSC-CM treated with control media (4.5 mM K+), media 
with increasing potassium concentrations (9–12 mM K+), or 10% sRBC collected from RBC units aged 7–40 days. The heat map 
corresponds to the spontaneous beating rate. B, Biosignals recorded from hiPSC-CM show a decline in beating rate with elevated 
potassium concentrations. C, Percent change in beating rate following treatment with elevated potassium concentrations, compared 
with baseline. D, Biosignals show a decline in the beating rate with “older” sRBC samples (day 35–40) but not “fresh” sRBC samples (day 
7). E, Percent change in beating rate following sRBC treatment, compared with baseline. Mean±SEM, n=12–24, *Significantly different 
from baseline, P<0.05. BPM indicates beats per minute; hiPSC-CM, human induced pluripotent stem cell–derived cardiomyocytes; 
RBC, red blood cell; and sRBC, supernatant from red blood cell units.
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R2 = 0.999, P=0.01). Notably, treatment did not ap-
pear to have a lasting effect on cardiomyocyte vi-
ability, as the beating rate quickly returned to normal 
after washing out the sRBC or hyperkalemic media 
(Figure 7).
DISCUSSION
Clinical case reports have documented transfusion-
associated hyperkalemia, which can lead to con-
duction disturbances, ventricular tachycardias, and/
or cardiac arrest.14,15,18,19,22,32,52 Furthermore, studies 
suggest that transfusion-associated adverse events 
may be associated with the storage age of blood 
products, as RBCs undergo a cascade of morpho-
logical, biochemical, and metabolic changes over 
time that are collectively termed the “RBC storage 
lesion” or “metabolic aging.”14,18,19,76 This study is the 
first to demonstrate that “older” blood products may 
directly impact myocardial automaticity and electri-
cal conduction, using experimental cardiac models. 
Importantly, we show that supernatant collected from 
“fresh” RBC units (7 days postdonor collection) had 
no effect on heart rate, sinus node function, atrial or 
atrioventricular conduction, or myocardial refractori-
ness in an isolated, whole heart model. A follow-up 
study in hiPSC-CM revealed that supplementation 
with 10% sRBC from “fresh” units (day 7) caused 
a modest increase in the spontaneous beating rate 
over time, which may be attributed to mild hyper-
kalemia (5.8±0.2 mM K+). In comparison, whole heart 
preparations exposed to supernatant from aged 
RBC units (>30 days postcollection) displayed brady-
cardia, slowed atrial and atrioventricular conduction, 
and an increase in the refractoriness of the ventricle 
and AV node. Notably, other groups have suggested 
that the maximal allowable RBC storage duration be 
reduced from 42 to 35 days, because of increased 
hemolysis and a sharp increase in nontransferrin-
bound iron after 5  weeks in refrigerated storage.24 
Although we did not measure either free iron or non-
transferrin-bound iron levels in this study, our results 
closely align with this conclusion, as electrophysi-
ological disturbances were predominately observed 
in units stored 30+ days postdonor collection.
Mechanistic Links Between RBC 
Transfusion and Adverse Cardiac 
Outcomes
Blood transfusion complications include an increased 
risk of bradycardia and cardiac arrest, which may be 
precipitated by an elevated potassium level in the 
supernatant of RBC units.14,15,21,22,52 As extracellular 
potassium increases, electrochemical gradients are 
diminished and the cardiomyocyte resting membrane 
potential becomes less negative.54,70,72 Accordingly, 
mild hyperkalemia can enhance cardiomyocyte ex-
citability, similar to our observation with day 7 sRBC 
treatment in hiPSC-CM. However, with more severe 
hyperkalemia, the change in resting membrane po-
tential decreases the availability of voltage-gated 
sodium channels that are critical to depolarization 
and myocardial excitability.54 Accordingly, severe hy-
perkalemia is marked by sinus node dysfunction and 
sinus arrest.53 Similar observations were observed in 
our study when cardiac preparations were exposed 
to increasing potassium concentrations, a prominent 
biomarker of RBC storage lesion that can, at least 
in part, contribute to the electrical disturbances ob-
served in this study.
As described above, hyperkalemia shifts the rest-
ing membrane potential and reduces the availability of 
voltage-gated sodium channels. As the action poten-
tial upstroke slows, electrical conduction slows, which 
manifests as a prolongation of P-waves, PR interval, 
and QRS interval time.54,70,72 Atrial cardiomyocytes are 
the most sensitive to elevated potassium concentra-
tions, followed by the ventricular myocardium and then 
specialized conductive tissue, including the sinoatrial 
node and bundle of His.54,70,72 Accordingly, electrical 
disturbances attributed to high [K+] are initially ob-
served as widened p-waves with shorter amplitudes, 
followed by atrioventricular and ventricular conduc-
tion delays as extracellular [K+] continues to increase. 
Instead of a gradual change in cardiac parameters, we 
observed a global depression in electrical conduction 
that was largely limited to sRBC samples near expira-
tion and/or 10 to 12 mM K+ perfusion. The latter may 
be attributed to the sensitivity of our model system,71 
species-specific differences in ion channel expres-
sion and electrophysiology,74,75 and/or other attributes 
of the RBC storage lesion (eg, lactate, free-iron, and 
plasticizer leaching) that may have additional effects on 
cardiac electrophysiology.24,25,27,63,77
Although not investigated in the present study, 
phthalate chemical exposure is another potential 
contributor to heart rate slowing and sinus node dys-
function. Phthalate chemicals are frequently used as 
plasticizers in blood bags, and studies have shown 
that storage age is associated with an accumulation 
of harmful phthalate chemicals in the supernatant of 
stored RBC products (18-fold increase, day 5 versus 
42 postdonor collection).77 Phthalate chemical expo-
sure has been associated with bradycardia in vivo,78 in 
vitro,79 and using an isolated heart model.80 Moreover, 
our laboratory previously reported that phthalate plasti-
cizers can lead to sinus node dysfunction in an isolated 
heart model, delaying SNRT by 54% compared with 
control.63 Additional studies are needed to investigate 
the additive effects that may result from hyperkalemia 
and phthalate chemical exposure.
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Clinical Implications
In the current study, we focused our attention on hy-
perkalemia as 1 potential mechanism for the electro-
physiology disturbances observed in our model system 
after exposure to “old” RBC samples. Hyperkalemia 
has been reported in >70% of adult trauma patients 
following transfusion,18 and observed in 18% to 23% 
of pediatric trauma patients following transfusion.33 
Moreover, Smith et al. reported that an increase in 
serum potassium levels (5.9–9.2 mEq/L) was associ-
ated with a higher risk of cardiac arrest,15 which is more 
likely to occur following rapid transfusion, large-volume 
transfusion, or in cases of low cardiac output that 
impairs the redistribution of potassium.14,19 Potential 
solutions to help mitigate the risk of hyperkalemia in-
clude prebypass filtering,81 washing RBCs,21 or limiting 
RBC storage duration.14,15,18,20,24 Notably, longer blood 
storage duration has been associated with subopti-
mal outcomes in high-risk pediatric surgery cases12 
and cardiac operations.17,20 Recent randomized con-
trolled trials have indicated that transfusion of “fresh” 
blood (eg, 1–10  days) does not decrease the risk of 
mortality when compared with standard of care (eg, 
2–3 weeks).44-48 However, much less is known about 
the safety of prolonged RBC storage (eg, 30–42 days) 
or the impact of “old” blood products on secondary 
cardiac end points.35,49 Accordingly, expert panels 
have highlighted the lack of evidence-based data to 
reach consensus on the safety of RBC storage age 
in relation to critically ill children, including those un-
dergoing surgical repair for congenital heart defects 
or those undergoing extracorporeal membrane oxy-
genation.82,83 The presented study highlights the im-
portance of studying the direct impact of RBC storage 
lesion on end-organ function, with an emphasis on 
cardiac electrophysiology given the sensitivity of the 
heart to electrolyte disturbances.
LIMITATIONS
The scope of our study was limited to the effects of 
acute cardiac exposure to supernatant collected from 
RBC units. Whole heart and cardiomyocyte models 
were used to investigate the direct effects of sRBC-
mediated biochemical disturbances on electrical ac-
tivity. Although hiPSC-CM are frequently employed 
in preclinical testing, it is important to note that these 
cells can display a less mature phenotype compared 
with adult cardiomyocytes.84 Moreover, in vitro and ex 
vivo results may differ from those observed in vivo, with 
an intact vascular and autonomic nervous system. To 
mimic patient exposure following a large transfusion, 
we estimated 10% supernatant volume exposure from 
reconstituted blood, based on volumes reported in 
trauma cases, cardiac surgery, and/or extracorporeal 
membrane oxygenation studies. Additional studies are 
warranted to assess additional effects that may result 
from reconstituted blood containing aged RBCs, or 
the risk to sensitive populations including those with 
low cardiac output. Further studies are warranted to 
investigate alternative mechanisms that may contrib-
ute to cardiovascular dysfunction, including additional 
biochemical and metabolic alterations in stored RBC 
units.26,36,77
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